NasdaqGS - Nasdaq Real Time Price USD

QuidelOrtho Corporation (QDEL)

Compare
26.39
-2.47
(-8.54%)
As of 3:47:31 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,782,900
2,782,900
2,997,800
3,266,000
1,698,600
Cost of Revenue
1,496,400
1,496,400
1,500,700
1,329,800
420,300
Gross Profit
1,286,500
1,286,500
1,497,100
1,936,200
1,278,300
Operating Expense
1,240,700
1,240,700
1,240,100
953,700
362,700
Operating Income
45,800
45,800
257,000
982,500
915,600
Net Non Operating Interest Income Expense
-188,900
-188,900
-176,700
-75,300
-400
Other Income Expense
-1,988,400
-1,988,400
-109,400
-171,300
-14,900
Pretax Income
-2,131,500
-2,131,500
-29,100
735,900
900,300
Tax Provision
-79,500
-79,500
-19,000
187,200
196,100
Net Income Common Stockholders
-2,052,000
-2,052,000
-10,100
548,700
704,200
Diluted NI Available to Com Stockholders
-2,052,000
-2,052,000
-10,100
548,700
704,200
Basic EPS
-30.54
--
-0.15
9.66
16.74
Diluted EPS
-30.54
--
-0.15
9.56
16.43
Basic Average Shares
67,200
--
66,800
56,800
42,078
Diluted Average Shares
67,200
--
66,800
57,400
42,874
Total Operating Income as Reported
-1,960,900
-1,960,900
139,100
843,700
906,000
Total Expenses
2,737,100
2,737,100
2,740,800
2,283,500
783,000
Net Income from Continuing & Discontinued Operation
-2,052,000
-2,052,000
-10,100
548,700
704,200
Normalized Income
-144,008.10
-144,008.10
60,052
670,447.20
715,930
Interest Income
2,600
2,600
5,500
1,300
300
Interest Expense
188,300
188,300
178,900
74,500
300
Net Interest Income
-188,900
-188,900
-176,700
-75,300
-400
EBIT
-1,943,200
-1,943,200
149,800
810,400
900,600
EBITDA
-1,489,800
-1,489,800
607,000
1,094,000
953,300
Reconciled Cost of Revenue
1,246,400
1,246,400
1,248,300
1,178,700
395,000
Reconciled Depreciation
453,400
453,400
457,200
283,600
52,700
Net Income from Continuing Operation Net Minority Interest
-2,052,000
-2,052,000
-10,100
548,700
704,200
Total Unusual Items Excluding Goodwill
-1,981,300
-1,981,300
-88,800
-163,200
-15,000
Total Unusual Items
-1,981,300
-1,981,300
-88,800
-163,200
-15,000
Normalized EBITDA
491,500
491,500
695,800
1,257,200
968,300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-73,308.10
-73,308.10
-18,648
-41,452.80
-3,270
12/31/2021 - 2/1/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TNDM Tandem Diabetes Care, Inc.
16.75
-4.88%
 
NVCR NovoCure Limited
16.12
-4.90%
 
MASI Masimo Corporation
149.02
-9.45%
 
QTRX Quanterix Corporation
4.8500
-13.24%
 
LIVN LivaNova PLC
34.09
-4.58%
 
BIO Bio-Rad Laboratories, Inc.
233.58
-6.26%
 
INSP Inspire Medical Systems, Inc.
144.44
-6.11%
 
GMED Globus Medical, Inc.
70.42
-5.20%
 
DXCM DexCom, Inc.
66.79
-0.07%
 
HAE Haemonetics Corporation
58.99
-3.35%